Starbucks Holds Hiring Event for Refugees in San Diego, TB
Starbucks Holds Hiring Event for Refugees in San Diego, TB Rates Among Highest in Country
Starbucks held a hiring event exclusively for refugees in El Cajon, California on Tuesday, part of its recently announced commitment to hire more than 10,000 refugees over the next five years.
El Cajon is located in San Diego County, where more than 20,000 refugees have have been resettled by the federal government in the past nine and a half years since the beginning of Fiscal Year 2008.
A 2013 study from a research team led by Dr. Timothy Rodwell, “an associate professor and physician in the Division of Global Health at UCSD [University of California at San Diego]” that “analyzed data from LTBI [latent tuberculosis infection] screening results of 4,280 refugees resettled in San Diego County between January 2010 and October 2012,” noted that “San Diego County, in California, is a leading refugee resettlement site, and it also has one of the highest rates of active TB in the country, with an incidence rate of 8.4 cases per 100 000 people in 2011.” (The incidence rate in the entire population in the United States in 2016 was 2.9 per 100,000).
The study, which was funded in part by the National Institutes of Health, found that, of the 4,280 refugees resettled in San Diego County during the 34 months beginning in January 2010:
advertisement
Nine hundred sixteen refugees (21.4%) in the study had a positive QFT-GIT result (Table 1). Of those, 823 (89.8%) had a normal chest radiograph and were diagnosed with LTBI (Figure 1). Sixty-one (6.7%) did not receive a chest radiograph; 14 (1.5%) had an abnormal result that was consistent with active TB; and 18 (2.0%) had an abnormal result that was not consistent with active TB.
In other words, the incidence of active TB among the 4,280 refugees who were resettled in San Diego County between January 2010 and October 2012 was 327 per 100,000, more than 100 times greater than the incidence of active TB among the entire population of the United States in 2016.
About four percent of the entire population of the United States tests positive for latent TB infection. Around 10 percent of those with LTBI will develop active TB at some point in their lives. The triggering mechanism to activate latent TB is not entirely understood, but high levels of stress, crowded living situations, poor public health practices, the presence of other diseases that lower the immune system, and behavioral conduct–such as smoking–appear to increase the chances of activation.
The 21.4 percent of refugees in the San Diego County study who tested positive for latent TB infection is about five times the national average.
Breitbart News contacted Starbucks to learn if their refugee hiring process will include mandatory testing for latent and active TB, but has not received a response.
The Starbucks refugee hiring event will be held at the San Diego offices of the International Rescue Committee, one of the top nine voluntary agencies (VOLAGS) that are paid over $1 billion each year to resettle refugees in the United States.
KGTV reported:
About 30 Starbucks managers will conduct on-the-spot interviews at the International Rescue Committee’s office located at 131 E. Main Street in El Cajon from 11 a.m. to 1:30 p.m. on Tuesday, Aug. 8. Applicants are encouraged to visit Starbucks online career center prior to the event and bring resumes along with them. The store managers will talk to the refugee applicants about what it’s like to work for Starbucks and review qualifications for the barista position.
The world’s largest coffee chain said it would focus initial efforts on markets where refugee need is greatest and there’s a store base to meet the need.
According to state and federal data, San Diego fits the bill.
No other California county has received more refugees during the past decade than San Diego county.
In 2016, San Diego settled 3,100 refugees, along with 520 military interpreters on special immigrant visas.
California, like most states, requires TB testing for health care workers. Employees of restaurants are not required by California law to be tested for TB prior to hiring.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...
Continue Reading
NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...
Continue Reading
A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...
Continue Reading
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...
Continue Reading
In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...
Continue Reading
Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...
Continue Reading
New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...
Continue Reading
Top 5 Most Recently Viewed Articles
The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...
Continue Reading
Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...
Continue Reading
LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...
Continue Reading
Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...
Continue Reading
Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....
Continue Reading